You are here: Industry Insights > Alzheimer's

News List

How neurons fend off Alzheimer’s with a cellular broom that clears the toxic tau protein fiercebiotech
December 18, 2018
When the protein tau builds up inside the neurons of the brain, the cells become impaired and eventually die in a process that’s been implicated in Alzheimer’s and other neurodegenerative diseases.
First Alzheimer's drug from Eisai/UCL alliance to enter clinical trials pharmatimes
December 07, 2018
The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.
2 studies use retinal scans to potentially identify earlier signs of Alzheimer’s disease fiercebiotech
November 02, 2018
Two studies showed that noninvasive eye scans measuring the thickness of the retina can provide a window into the early signs of Alzheimer’s disease, with the goal of providing a quick, inexpensive...
Allergan adds actor Scott Eastwood to Alzheimer's effort for even more celebrity firepower fiercepharma
September 30, 2018
Allergan already has a laundry list of celebrities backing its Alzheimer’s awareness push, but that didn’t stop it from adding one more this week.
World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime worldpharmanews
September 30, 2018
Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest global survey to date investigating perceptions of Alzheimer's disease.
World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime worldpharmanews
September 20, 2018
Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest global survey to date investigating perceptions of Alzheimer's disease.
How tau disrupts brain-cell connections in Alzheimer’s disease fiercebiotech
September 06, 2018
Scientists found a new mechanism in Alzheimer's where an abnormal form of tau disrupts nuclear pore complex that handles molecular transport between nucleus and cytoplasm. (Colin Behrens)
Second time lucky? Alzheon tries for much-reduced IPO fiercebiotech
August 29, 2018
Alzheon is planning a phase 2b trial.
Substance abuse, neurological disease and more can speed up brain aging fiercebiotech
August 28, 2018
Brain scan analysis showed an association between premature brain aging and certain disorders and behaviors. (Getty/Rawpixel)
Biogen's Spinraza zooms through blockbusterland, but analysts are fixated on Alzheimer's data fiercepharma
July 25, 2018
Biogen's Spinraza took a 100% leap and its multiple sclerosis franchise mostly held its own in the second quarter, but analysts weren't much interested in those topics on Tuesday morning's earnings call.

Previous page 1 2 3 4 Next page